Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …

T Santo, B Clark, M Hickman, J Grebely… - JAMA …, 2021 - jamanetwork.com
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …

Increasing overdose deaths among Black Americans: a review of the literature

JB Gibbons, SJ Harris, KT Solomon… - The Lancet …, 2023 - thelancet.com
In 2020, opioid overdose fatalities among Black Americans surpassed those among White
Americans for the first time in US history. This Review analyses the academic literature on …

[HTML][HTML] Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland

T Schwarz, J Anzenberger, M Busch, G Gmel… - Drug and Alcohol …, 2024 - Elsevier
Background and Aims OAT is a well developed and successful treatment strategy for opioid
dependent patients in Europe. It has significantly contributed to the fight against the HIV and …

Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder: Study examines racial and ethnic disparities in the use of medications …

B Andraka-Christou - Health Affairs, 2021 - healthaffairs.org
Social discourse about the opioid crisis in the US has focused on White populations, even
though opioid-related deaths have grown at a higher rate among people of color than …

Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study

A McAuley, R Fraser, M Glancy, A Yeung… - The Lancet Public …, 2023 - thelancet.com
Background Drug-related death (DRD) rate in Scotland, UK, has increased rapidly to one of
the highest in the world. Our aim was to examine the extent to which opioid-agonist therapy …

Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US

GJ Stahler, J Mennis, DA Baron - Drug and Alcohol Dependence, 2021 - Elsevier
Background This study examines racial/ethnic disparities in the use of medications for opioid
use disorder (MOUD) in residential treatment and the influence of race/ethnicity on the …

Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support …

M Selfridge, K Card, T Kandler, E Flanagan… - International Journal of …, 2022 - Elsevier
Abstract Aims In March 2020, British Columbia issued Risk Mitigation Guidance (RMG) to
support prescribing of pharmaceutical alternatives to illicit drugs, in order to reduce risk for …

'I don't chase drugs as much anymore, and I'm not dead': Client reported outcomes associated with safer opioid supply programs in Ontario, Canada

RA Schmidt, N Kaminski, DT Kryszajtys… - Drug and Alcohol …, 2023 - Wiley Online Library
Introduction The ongoing opioid overdose crisis, which has killed over 30,000 people in
Canada since 2016, is driven by the volatility of an unregulated opioid drug supply …

[PDF][PDF] Methadone treatment for people who use fentanyl: recommendations

L Bromley, M Kahan… - Toronto …, 2021 - rx.comprehensivetreatmentclinic …
Fentanyl and its analogues have played an increasing role in opioid overdose deaths
across the country over the past decade. Such high-potency, non-prescription opioids are …

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

BE Biondi, B Vander Wyk, EF Schlossberg… - Addiction Science & …, 2022 - Springer
Background Medication treatment for opioid use disorder (OUD)(MOUD; buprenorphine and
methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to …